157 related articles for article (PubMed ID: 6362357)
1. The forty-year-old mutation theory of Luria and Delbrück and its pertinence to cancer chemotherapy.
Skipper HE
Adv Cancer Res; 1983; 40():331-63. PubMed ID: 6362357
[No Abstract] [Full Text] [Related]
2. "Rescue" techniques in cancer chemotherapy: use of leucovorin and other rescue agents after methotrexate treatment.
Bertino JR
Semin Oncol; 1977 Jun; 4(2):203-16. PubMed ID: 301662
[No Abstract] [Full Text] [Related]
3. Gene amplification in drug resistance: of mice and men.
Curt GA; Cowan KH; Chabner BA
J Clin Oncol; 1984 Jan; 2(1):62-4. PubMed ID: 6699659
[No Abstract] [Full Text] [Related]
4. [Kinetics of breast neoplasms].
Surbone A; Norton L
Minerva Med; 1994; 85(1-2):7-16. PubMed ID: 8152580
[TBL] [Abstract][Full Text] [Related]
5. Some thoughts on resistance to cancer chemotherapy.
Carter SK
Cancer Treat Rev; 1984 Mar; 11 Suppl A():3-7. PubMed ID: 6375863
[No Abstract] [Full Text] [Related]
6. The fixed-size Luria-Delbruck model with a nonzero death rate.
Komarova NL; Wu L; Baldi P
Math Biosci; 2007 Nov; 210(1):253-90. PubMed ID: 17583754
[TBL] [Abstract][Full Text] [Related]
7. High-dose methotrexate with folinic acid rescue.
Bender JF; Grove WR; Fortner CL
Am J Hosp Pharm; 1977 Sep; 34(9):961-5. PubMed ID: 333910
[TBL] [Abstract][Full Text] [Related]
8. [Present state in synchronization therapy of malignant tumors and acute leukemias (author's transl)].
Sauer H; Wilmanns W
Klin Wochenschr; 1976 Mar; 54(5):197-202. PubMed ID: 768630
[TBL] [Abstract][Full Text] [Related]
9. The optimal scheduling of two drugs with simple resistance for a problem in cancer chemotherapy.
Murray JM
IMA J Math Appl Med Biol; 1997 Dec; 14(4):283-303. PubMed ID: 9415996
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy--theory and practice.
Capizzi RL; Keiser LW; Sartorelli AC
Semin Oncol; 1977 Jun; 4(2):227-53. PubMed ID: 327555
[No Abstract] [Full Text] [Related]
11. Improved inference of mutation rates: II. Generalization of the Luria-Delbrück distribution for realistic cell-cycle time distributions.
Oprea M; Kepler TB
Theor Popul Biol; 2001 Feb; 59(1):49-59. PubMed ID: 11243928
[TBL] [Abstract][Full Text] [Related]
12. Haldane's solution of the Luria-Delbrück distribution.
Sarkar S
Genetics; 1991 Feb; 127(2):257-61. PubMed ID: 2004702
[No Abstract] [Full Text] [Related]
13. The use of cell kinetics in the development of drug combinations.
Valeriote FA
Pharmacol Ther; 1979; 4(1):1-33. PubMed ID: 461499
[No Abstract] [Full Text] [Related]
14. Discussion on research methods of bacterial resistant mutation mechanisms under selective culture--uncertainty analysis of data from the Luria-Delbrück fluctuation experiment.
Jin J; Wei G; Yang W; Zhang H; Gao P
Sci China Life Sci; 2012 Nov; 55(11):1007-21. PubMed ID: 23160830
[TBL] [Abstract][Full Text] [Related]
15. Alternation of chemotherapy and radiotherapy in cancer management. I. Summary of the Division of Cancer Treatment Workshop.
Looney WB; Goldie JH; Little JB; Hopkins HA; Read EJ; Wittes R
Cancer Treat Rep; 1985; 69(7-8):769-75. PubMed ID: 4016787
[No Abstract] [Full Text] [Related]
16. A model for tumor response to chemotherapy: an integration of the stem cell and somatic mutation hypotheses.
Goldie JH; Coldman AJ
Cancer Invest; 1985; 3(6):553-64. PubMed ID: 3910195
[No Abstract] [Full Text] [Related]
17. Intensive cytotoxic chemotherapy.
Bagshawe KD
J R Coll Physicians Lond; 1971 Jan; 5(2):157-66. PubMed ID: 4131399
[No Abstract] [Full Text] [Related]
18. Eosinophilic leukemia. Remission with vincristine and hydroxyurea.
Chusid MJ; Dale DC
Am J Med; 1975 Aug; 59(2):297-300. PubMed ID: 1155486
[TBL] [Abstract][Full Text] [Related]
19. [High-dose treatment].
Takaku F
Gan To Kagaku Ryoho; 1985 Apr; 12(4):830-8. PubMed ID: 3872631
[TBL] [Abstract][Full Text] [Related]
20. Fluctuation analysis on mutation models with birth-date dependence.
Mazoyer A
Math Biosci; 2018 Sep; 303():83-100. PubMed ID: 29932952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
